House introduces FDA Modernization Act 3.0
/ 1 min read
Table of Contents
Representative Cathy McMorris Rodgers introduced this bill in the House of Representatives. It seeks to update how the Food and Drug Administration (FDA) evaluates new medical products, specifically focusing on alternatives to animal testing.
Why it matters: This would change the technical requirements for how pharmaceutical and medical device companies prove their products work, potentially reducing the reliance on animal testing during early development stages.
Who it affects
- Pharmaceutical and biotechnology companies
This information comes from Congress.gov regarding a bill introduced in the House; check the official text for specific technical requirements before relying on it.
Agency: House
Source: Congress.gov — read the official document